| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ATXI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Herskowitz Neil | Director | Sell | 23 | $2.00 | $46.00 | -19.2% | |
| Nov 5, 2024 | Kranzler Jay D | Director | Sell | 61 | $2.24 | $136.64 | -9.8% | |
| Sep 30, 2024 | Kranzler Jay D | Director | Buy | 500 | $2.50 | $1,249.70 | +416.7% | |
| Dec 11, 2023 | Davidow Robert L | 10% Owner | Sell | 617,000 | $0.14 | $86,560.00 | -88.5% | |
| Sep 8, 2023 | Rosenwald Lindsay A Md64 | Director | Buy | 348,675 | $0.72 | $251,046.00 | +6,179% | |
| Oct 11, 2022 | Invagen Pharmaceuticals, Inc. | 10% Owner | Sell | 388,888 | $7.71 | $2,999,882.03 | -100% | |
| Sep 15, 2021 | Vazzano Joseph Walter75 | Chief Financial Officer | Sell | 7,160 | $1.62 | $11,599.20 | -9.9% | |
| May 6, 2021 | Herskowitz Neil | Director | Buy | 2,500 | $3.99 | $9,975.00 | +1.9% | |
| Aug 20, 2020 | Vazzano Joseph Walter75 | Chief Financial Officer | Sell | 3,840 | $12.13 | $46,579.20 | -6.3% | |
| Mar 10, 2020 | Vazzano Joseph Walter75 | Chief Financial Officer | Buy | 3,389 | $7.96 | $26,981.66 | +5.9% |